Blueberries Medical has completed the acquisition of BBV Labs, a corporation formed under the laws of the Republic of Panama.
"With the Purchase Agreement Blueberries will have the rights to acquire cannabis cultivation, processing, manufacturing and other rights in Argentina, pursuant to a definitive joint venture agreement with the Argentinean state-owned company Cannabis Avatara, S.E. and BBV," Blueberries team explains. "The Joint Venture with Cannava allows the Company to develop and cultivate cannabis on a 3.2 million square foot (74 acres or 30 hectares) prime agricultural property. Cannava will contribute the land to the Joint Venture as well as all required permits and authorization necessary to import seeds, cultivate, grow and harvest cannabis, process cannabis and extract cannabis oil and other derivative products for scientific, medicinal and therapeutic purposes and to export cannabis and derivative products and import and export related equipment and products."
"The Purchase Agreement was amended to change its terms to reflect the payment of the purchase price to be satisfied by Blueberries issuing 3,000,000 common shares in the capital of the Company to the vendors."
For more information:
Blueberries Medical Corp.
Calle 93 # 15 - 51 Of. 406
Bogotá, Colombia
(57) 1 794-1798
[email protected]
blueberriesmed.com